Tag Archives: Biotechnology and Medical Research (TRBC)

Gilead: FDA could extend the use of remdesivir despite mixed data

(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …

Read More »